GlobeNewsWire
30 Jul 2026, 23:33 UTC · 11w ago
ERAS 11-DAY DEADLINE ALERT: HBSS Investigating Pending Claims Against Erasca (ERAS) in Securities Class Action Arising from Patent Litigation and Patient Safety Risks
Impact · against what's priced in
The announcement of a class action investigation into Erasca (ERAS) regarding safety and IP risks for ERAS-0015 is largely a lagging indicator, as the associated $2.8 billion market cap loss occurred in April 2026. For BRCB and EMBC, the mention of investigations into misleading financial statements introduces new legal risk, though the specific nature of those claims remains vague.
- BRCB−0.30
No priced-in read yet





